-11.59%
-18.78%
22.40%
87.78%
76.44%
54.66%
145.96%

Company Description

Pro-Dex, Inc.designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide.The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.


It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.The company was founded in 1978 and is headquartered in Irvine, California.

Market Data

Last Price 37.97
Change Percentage -11.59%
Open 43.07
Previous Close 42.95
Market Cap ( Millions) 124
Volume 98192
Year High 59.6
Year Low 16.18
M A 50 47.37
M A 200 29.17

Financial Ratios

FCF Yield 2.11%
Dividend Yield 0.00%
ROE 21.68%
Debt / Equity 54.45%
Net Debt / EBIDTA 148.52%
Price To Book 3.89
Price Earnings Ratio 18.35
Price To FCF 47.42
Price To sales 2.03
EV / EBITDA 12.13

Business Breakdown

Expected Mid-Term Growth

Segment nΒ°1 -> Medical Devices

Expected Growth : 3.5 %

What the company do ?

Pro-Dex, Inc. designs and manufactures medical devices, including surgical and orthopedic instruments, and implantable devices for various medical specialties.

Why we expect these perspectives ?

Pro-Dex, Inc.'s medical devices segment growth of 3.5% is driven by increasing demand for minimally invasive surgical instruments, expansion into emerging markets, and strategic partnerships. Additionally, advancements in robotics and artificial intelligence are fueling innovation, while an aging population and rising healthcare expenditure support sustained growth.

Segment nΒ°2 -> Repairs

Expected Growth : 3.2 %

What the company do ?

Repairs from Pro-Dex, Inc. offers repair services for medical devices, including surgical and anesthesia equipment, to extend their lifespan and ensure optimal performance.

Why we expect these perspectives ?

Pro-Dex, Inc.'s 3.2% growth in repairs is driven by increasing demand for medical devices, expansion into new markets, and strategic partnerships. Additionally, the company's focus on quality and customer satisfaction has led to repeat business and positive word-of-mouth, contributing to the growth.

Segment nΒ°3 -> NRE & Prototype

Expected Growth : 3.8 %

What the company do ?

NRE (Non-Recurring Engineering) and Prototype from Pro-Dex, Inc. refer to the initial product development phase, where a single unit or a small batch of a product is manufactured for testing and validation purposes.

Why we expect these perspectives ?

Pro-Dex Inc.'s NRE & Prototype segment growth of 3.8% is driven by increasing demand for medical devices, expansion into new markets, and investments in research and development. Additionally, the company's focus on innovation and quality has led to higher customer retention rates and new business opportunities.

Segment nΒ°4 -> Discounts & Other

Expected Growth : 2.8 %

What the company do ?

Discounts & Other from Pro-Dex, Inc. refers to miscellaneous revenue streams, including discounts, rebates, and other non-operating income.

Why we expect these perspectives ?

Pro-Dex, Inc.'s 2.8% growth in Discounts & Other is driven by increasing sales of medical device components, expansion into new markets, and strategic partnerships. Additionally, the company's focus on operational efficiency and cost reduction initiatives have contributed to the growth. Furthermore, the company's ability to negotiate better prices with suppliers has also positively impacted the segment.

Segment nΒ°5 -> Industrial and Scientific

Expected Growth : 3.9 %

What the company do ?

Industrial and Scientific from Pro-Dex, Inc. provides precision-engineered products and solutions for medical, scientific, and industrial applications.

Why we expect these perspectives ?

Pro-Dex Inc.'s Industrial and Scientific segment growth of 3.9% is driven by increasing demand for precision-engineered products, expansion into new markets, and strategic partnerships. Additionally, investments in research and development, coupled with a strong focus on innovation, have enabled the company to capitalize on emerging trends in the industrial and scientific sectors.

Segment nΒ°6 -> Dental and Component

Expected Growth : 3.6 %

What the company do ?

Pro-Dex, Inc.'s Dental and Component segment offers dental and surgical instruments, including endodontic and orthodontic instruments, and component parts for medical devices.

Why we expect these perspectives ?

Pro-Dex, Inc.'s Dental and Component segment growth of 3.6% is driven by increasing demand for dental implants, rising adoption of digital dentistry, and growing need for precision-engineered components in medical devices. Additionally, the company's focus on innovation, quality, and customer service has led to market share gains and expansion into new geographies.

Pro-Dex, Inc. Products

Product Range What is it ?
Medical Device Products Pro-Dex, Inc. designs and manufactures medical device products, including surgical and orthopedic instruments, and implantable devices.
Laser Machining Services Pro-Dex, Inc. offers laser machining services for precision cutting, drilling, and welding of medical devices and instruments.
Clean Room Assembly and Packaging Pro-Dex, Inc. provides clean room assembly and packaging services for medical devices, ensuring sterile and contamination-free products.
Engineering and Design Services Pro-Dex, Inc. offers engineering and design services for medical devices, including design, development, and testing.

Pro-Dex, Inc.'s Porter Forces

Pro-Dex, Inc. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the evolving nature of the medical device industry.

Pro-Dex, Inc. has a diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products are critical to its customers' operations, making it difficult for customers to negotiate prices.

Pro-Dex, Inc. relies on a few key suppliers for critical components, giving them some bargaining power. However, the company's strong relationships with suppliers and its ability to negotiate contracts mitigate this risk.

The medical device industry has high barriers to entry, including regulatory hurdles and significant capital requirements, making it difficult for new entrants to compete with Pro-Dex, Inc.

The medical device industry is highly competitive, with several established players competing for market share. Pro-Dex, Inc. must continually innovate and improve its products to maintain its market position.

Capital Structure

Value
Debt Weight 31.89%
Debt Cost 4.80%
Equity Weight 68.11%
Equity Cost 6.69%
WACC 6.09%
Leverage 46.82%

Historical Valuation

Price/Earnings Ratio

Margin Valuation

Peers Valuation

Competitors

Company Rational
NEPH Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and …
OSUR OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in …
WRBY Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and …
LMAT LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing …
UTMD Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD …

Peers Metrics

DCF BETA

Parameters

Short Term Growth
Short term Time
Long-Term Growth
WACC
Target Price
37.97$
Current Price
37.97$
Potential
-0.00%

Expected Cash-Flows

Scoring Insights

Peers Group Analysis

πŸ₯‡

LeMaitre Vascular Logo
LeMaitre Vascular
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯ˆ

Utah Medical Products Logo
Utah Medical Products
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯‰

Pro-Dex Logo
Pro-Dex
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

4

Warby Parker Logo
Warby Parker
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

5

OraSure Technologies Logo
OraSure Technologies
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

6

Nephros Logo
Nephros
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->